Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
558 hedge funds and large institutions have $7.89B invested in Exact Sciences in 2025 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 176 increasing their positions, 195 reducing their positions, and 98 closing their positions.
17% more call options, than puts
Call options by funds: $83.1M | Put options by funds: $71.4M
0.67% less ownership
Funds ownership: 98.82% → 98.14% (-0.67%)
10% less repeat investments, than reductions
Existing positions increased: 176 | Existing positions reduced: 195
6% less funds holding
Funds holding: 594 → 558 (-36)
23% less capital invested
Capital invested by funds: $10.3B → $7.89B (-$2.38B)
28% less first-time investments, than exits
New positions opened: 71 | Existing positions closed: 98
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$353M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$86.5M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$32.6M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$32M |
| 5 |
Amundi
Paris,
France
|
+$32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$151M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$113M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$68.4M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$60.5M |
| 5 |
Millennium Management
New York
|
-$44.9M |
EXAS Hedge Fund Activity: Q1 2025 in Review
558 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2025, worth a combined $7.89B — down 23% from $10.3B a quarter earlier.
Sellers outnumbered buyers: 98 funds closed out of EXAS and 71 opened new positions — a net loss of 27 holders — while 195 trimmed existing stakes and 176 added.
The largest buyer was Fidelity Investments, adding an estimated $353M. The largest seller was JP Morgan Chase, cutting an estimated $151M.
- 558 institutional investors held Exact Sciences (EXAS) as of Q1 2025, down from 594 in Q4 2024.
- Funds reported $7.89B of Exact Sciences stock for Q1 2025, down 23% quarter-over-quarter.
- 71 funds opened new Exact Sciences positions in Q1 2025 and 98 closed out, a net change of -27 holders.
- The largest Exact Sciences buyer in Q1 2025 was Fidelity Investments, an estimated $353M added.
- The largest Exact Sciences seller in Q1 2025 was JP Morgan Chase, an estimated $151M sold.
Based on aggregated 13F filings for Q1 2025.